InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Karyopharm Therapeutics Inc.

KPTI Clue Score22
United States Fiscal year ends December CIK 0001503802 Results filed 13 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

10
Insider
Date
Role
Action
Shares
Price
Amount
Richard A. Paulson
7 Aug 2023
President and CEO
Sold on a plan
3,722
$1.72
$6.40K
Stuart Poulton
28 Jul 2023
EVP, Chief Development Officer
Sold on a plan
2,845
$1.70
$4.84K
Richard A. Paulson
5 Jul 2023
President and CEO
Sold on a plan
3,538
$1.72
$6.09K
Sohanya Roshan Cheng
8 Jun 2023
EVP & Chief Commercial Officer
Sold on a plan
1,839
$2.35
$4.32K
Richard A. Paulson
5 Jun 2023
President and CEO
Sold on a plan
3,536
$2.24
$7.92K
Michael Mason
2 Jun 2023
EVP, CFO & Treasurer
Sold on a plan
631
$2.22
$1.40K
Richard A. Paulson
4 May 2023
President and CEO
Sold on a plan
3,805
$3.35
$12.75K
Reshma Rangwala
20 Apr 2023
EVP & Chief Medical Officer
Sold on a plan
6,655
$4.05
$26.95K
Reshma Rangwala
20 Apr 2023
EVP & Chief Medical Officer
Sold on a plan
115
$4.03
$463.07
Richard A. Paulson
4 Apr 2023
President and CEO
Sold on a plan
3,497
$3.97
$13.88K
Showing 250 of 393 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 459
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 10
Sales on a Rule 10b5-1 plan 10
Sales straight out of an exercise 161
Sales at will 216
Transactions with no price 0
Shares from compensation/vesting 6,536,376
Sales filed before the plan box existed 119
History held since 13 Nov 2013